The inflammatory response aggravation in stable COPD patients' lower respiratory tract and lungs is aggravated, which is related to the enhanced expression of key Th17 cytokines, interleukin (IL)-6, and IL-17. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.